(TKO) TKO Holdings - Overview
Sector: Communication ServicesIndustry: Entertainment | Exchange NYSE (USA) | Currency USD | Market Cap: 15.333m | Total Return 25.5% in 12m
Stock: Live Events, Streaming Service, Merchandise, Sponsorships
| Risk 5d forecast | |
|---|---|
| Volatility | 42.0% |
| Relative Tail Risk | -18.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.74 |
| Alpha | 16.24 |
| Character TTM | |
|---|---|
| Beta | 0.420 |
| Beta Downside | 0.625 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.80% |
| CAGR/Max DD | 0.87 |
EPS (Earnings per Share)
Revenue
Risks
P/E ratio: 86.3467
Description: TKO TKO Holdings March 02, 2026
TKO Group Holdings, Inc. (NYSE: TKO) is a sports-and-entertainment conglomerate that owns and monetizes a portfolio of IP, most notably the UFC brand. It produces and licenses live events, TV programming, and digital content, operates the UFC Fight Pass streaming service, and generates revenue from merchandising, video games, apparel, and sponsorship/advertising sales. The company, incorporated in 2023 and headquartered in New York, is a subsidiary of Endeavor Group Holdings.
Recent metrics show UFC Fight Pass subscribers grew to roughly 1.2 million in Q4 2024, driving a 12% YoY increase in subscription revenue, while total UFC-related merchandise sales rose 8% year-over-year, reflecting strong fan engagement. The broader Movies & Entertainment sector is benefiting from a rebound in discretionary spending, with U.S. consumer confidence in entertainment reaching a six-month high of 106 (April 2024) and digital ad spend up 5% YoY, supporting TKO’s advertising inventory pricing power.
For a deeper quantitative view, you may want to explore ValueRay’s analyst tools.
Headlines to watch out for
- Media rights deals drive UFC and WWE revenue growth
- Live event ticket sales and site fees boost profitability
- IMG segment diversifies revenue through sports and entertainment services
- Consumer product licensing agreements contribute to brand value
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 195.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.05 > 1.0 |
| NWC/Revenue: 10.18% < 20% (prev 5.32%; Δ 4.86% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.29b > Net Income 195.4m |
| Net Debt (3.23b) to EBITDA (1.30b): 2.49 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (194.6m) vs 12m ago 13.13% < -2% |
| Gross Margin: 49.57% > 18% (prev 0.45%; Δ 4.91k% > 0.5%) |
| Asset Turnover: 33.59% > 50% (prev 29.44%; Δ 4.15% > 0%) |
| Interest Coverage Ratio: 4.01 > 6 (EBITDA TTM 1.30b / Interest Expense TTM 202.7m) |
Altman Z'' 0.29
| A: 0.03 (Total Current Assets 2.33b - Total Current Liabilities 1.85b) / Total Assets 15.50b |
| B: -0.05 (Retained Earnings -797.3m / Total Assets 15.50b) |
| C: 0.06 (EBIT TTM 813.0m / Avg Total Assets 14.10b) |
| D: -0.13 (Book Value of Equity -814.8m / Total Liabilities 6.25b) |
| Altman-Z'' Score: 0.29 = B |
Beneish M -2.23
| DSRI: 1.99 (Receivables 558.3m/221.4m, Revenue 4.74b/3.74b) |
| GMI: 0.91 (GM 49.57% / 44.94%) |
| AQI: 0.91 (AQ_t 0.79 / AQ_t-1 0.87) |
| SGI: 1.27 (Revenue 4.74b / 3.74b) |
| TATA: -0.07 (NI 195.4m - CFO 1.29b) / TA 15.50b) |
| Beneish M-Score: -2.23 (Cap -4..+1) = BBB |
What is the price of TKO shares?
Over the past week, the price has changed by -2.61%, over one month by -15.15%, over three months by -12.10% and over the past year by +25.54%.
Is TKO a buy, sell or hold?
- StrongBuy: 13
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TKO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 235.2 | 24.3% |
| Analysts Target Price | 235.2 | 24.3% |
TKO Fundamental Data Overview March 25, 2026
P/E Forward = 52.6316
P/S = 3.2381
P/B = 3.9298
P/EG = 1.4634
Revenue TTM = 4.74b USD
EBIT TTM = 813.0m USD
EBITDA TTM = 1.30b USD
Long Term Debt = 3.72b USD (from longTermDebt, last quarter)
Short Term Debt = 78.4m USD (from shortTermDebt, last quarter)
Debt = 4.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.23b USD (from netDebt column, last quarter)
Enterprise Value = 18.57b USD (15.33b + Debt 4.06b - CCE 831.1m)
Interest Coverage Ratio = 4.01 (Ebit TTM 813.0m / Interest Expense TTM 202.7m)
EV/FCF = 15.33x (Enterprise Value 18.57b / FCF TTM 1.21b)
FCF Yield = 6.52% (FCF TTM 1.21b / Enterprise Value 18.57b)
FCF Margin = 25.57% (FCF TTM 1.21b / Revenue TTM 4.74b)
Net Margin = 4.13% (Net Income TTM 195.4m / Revenue TTM 4.74b)
Gross Margin = 49.57% ((Revenue TTM 4.74b - Cost of Revenue TTM 2.39b) / Revenue TTM)
Gross Margin QoQ = 44.56% (prev 49.21%)
Tobins Q-Ratio = 1.20 (Enterprise Value 18.57b / Total Assets 15.50b)
Interest Expense / Debt = 1.45% (Interest Expense 58.9m / Debt 4.06b)
Taxrate = 11.90% (73.8m / 620.1m)
NOPAT = 716.2m (EBIT 813.0m * (1 - 11.90%))
Current Ratio = 1.26 (Total Current Assets 2.33b / Total Current Liabilities 1.85b)
Debt / Equity = 1.09 (Debt 4.06b / totalStockholderEquity, last quarter 3.74b)
Debt / EBITDA = 2.49 (Net Debt 3.23b / EBITDA 1.30b)
Debt / FCF = 2.67 (Net Debt 3.23b / FCF TTM 1.21b)
Total Stockholder Equity = 4.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.39% (Net Income 195.4m / Total Assets 15.50b)
RoE = 4.89% (Net Income TTM 195.4m / Total Stockholder Equity 4.00b)
RoCE = 10.53% (EBIT 813.0m / Capital Employed (Equity 4.00b + L.T.Debt 3.72b))
RoIC = 9.88% (NOPAT 716.2m / Invested Capital 7.25b)
WACC = 6.16% (E(15.33b)/V(19.40b) * Re(7.46%) + D(4.06b)/V(19.40b) * Rd(1.45%) * (1-Tc(0.12)))
Discount Rate = 7.46% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 100.0 | Cagr: 53.35%
[DCF] Terminal Value 87.85% ; FCFF base≈968.2m ; Y1≈1.19b ; Y5≈2.04b
[DCF] Fair Price = 676.5 (EV 55.98b - Net Debt 3.23b = Equity 52.75b / Shares 78.0m; r=6.16% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -13.37 | EPS CAGR: -12.11% | SUE: -0.56 | # QB: 0
Revenue Correlation: 86.38 | Revenue CAGR: 35.37% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.75 | Chg7d=+0.000 | Chg30d=-0.187 | Revisions Net=-3 | Analysts=8
EPS current Year (2026-12-31): EPS=5.52 | Chg7d=+0.000 | Chg30d=+0.054 | Revisions Net=-1 | Growth EPS=+144.1% | Growth Revenue=+22.2%
EPS next Year (2027-12-31): EPS=6.18 | Chg7d=+0.000 | Chg30d=+0.660 | Revisions Net=-2 | Growth EPS=+12.1% | Growth Revenue=+1.1%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.8% (Discount Rate 7.9% - Earnings Yield 1.2%)
[Growth] Growth Spread = +11.5% (Analyst 18.2% - Implied 6.8%)